False Claims Act Update & Alert
	Taxpayers Against Fraud Education Fund | Washington, D.C. | WWW.TAF.ORG           August 6, 2009
	.
	.
		Subscribe to this FREE Newsletter Enter your Email Powered by FeedBlitz n TAF Home Page n Previous Newsletters n Email editor   Please take a moment to forward this FREE electronic newsletter to others that might be interested!	State Zyprexa Deal in the Wings Eli Lilly is in “advanced discussions” with several states as it tries to settle still-outstanding FCA cases dealing with Zyprexa.  In expectation of a settlement, Lilly has taken a $105 million pretax charge.  In January, Lilly reached a $1.42 billion agreement with the Department of Justice over off-label marketing of Zyprexa, but some states refused to sign on to the DoJ deal saying they wanted more money. >> To read more
			Baxter Pays $6.8 Million to IL Baxter has agreed to pay Illinois $6.8 million for fraudulently inflating the average wholesale price of more than two dozen Baxter drugs.  Baxter is the eighth company to settle charges with Illinois; cases continue against three dozen other companies.   >> To read more
			Computer Assets to Pay $350,000 Computer Assets Inc. and its principals have agreed to pay $350,000 and surrender up to $35 million in pending E-Rate applications to settle charges the company violated the False Claims Act in connection with the FCC's E-Rate program.  >> To read more
			Tulare Healthcare Settlement Tulare Local Healthcare District, Tulare District Healthcare System and Tulare District Hospital have collectively agreed to pay more than $2.4 million to settle charges they submitted claims to Medicare as part of doctor-referral kickback scheme. >> To read more
			Allegran's Botox Problem Allegran, the maker of Botox, has been subpoenaed by DoJ over possible off-label promotion of Botox as a treatment for migraine.  Allegran says it's nonsense even as they apply for FDA approval for Botox as a migraine treatment. >> To read more
			.....